Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / OPTN - OptiNose: Underappreciated Potential


OPTN - OptiNose: Underappreciated Potential

  • The primary and secondary endpoints were met in phase 3 clinical trial.
  • The company's revenue was $22.5 million in Q4 2021, up 38% from Q4 2020.
  • The total number of Xhance prescriptions was 93.7 thousand, up 26.8% compared to the previous year.

For further details see:

OptiNose: Underappreciated Potential
Stock Information

Company Name: OptiNose Inc.
Stock Symbol: OPTN
Market: NASDAQ
Website: optinose.com

Menu

OPTN OPTN Quote OPTN Short OPTN News OPTN Articles OPTN Message Board
Get OPTN Alerts

News, Short Squeeze, Breakout and More Instantly...